Ethambutol Hydrochloride 275.00 mg + Isoniazid 100.00 mg + Pyrazinamide 500.00 mg + Rifampicin 150.00 mg

FORECOX 150MG is a fixed-dose combination medication used in the treatment of tuberculosis. It consists of Rifampicin, Pyrazinamide, Isoniazid, and Ethambutol Hydrochloride, which act synergistically to combat Mycobacterium tuberculosis, the bacteria that causes tuberculosis. Rifampicin exhibits bactericidal activity by inhibiting the synthesis of RNA. Pyrazinamide works by disrupting the energy metabolism of the bacteria. Isoniazid inhibits the synthesis of cell wall components. Ethambutol Hydrochloride inhibits the synthesis of the cell wall by interfering with the bacteria's ability to incorporate mycolic acids. Together, these components provide a comprehensive approach to the management of tuberculosis infections.

Take FORECOX 150MG orally with or without food, as directed by your doctor. Follow the prescribed dosage and duration of treatment. It is important not to skip doses or stop the medication abruptly without proper medical guidance.

Allopathic

The contents and information provided here are solely intended to provide a general overview of the products and medicines and must be used for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. The information contained herein should not be used as a substitute for the advice of a qualified physician. For all queries or doubts related to your medical condition, we highly recommend that you consult your registered medical practitioner.